16 Sep 2021

Take a Breath: Selecting a Device for Inhaled Product Development

The future commercial success of any new inhaled medicine relies in a large part on the correct combination of formulation and device technology chosen for its delivery.

This presentation will benefit any drug developer considering an inhaled programme and aims to answer the following questions:

  • How are development targets and success criteria set for inhaled products?
  • What are the key factors influencing inhaled delivery platform selection?
  • How can phase-appropriate device selection accelerate an inhaled development programme?
  • This session was originally broadcast live as part of CPhI North America 2021

    Content provided by our supplier


    • GB
    • 2020
      On CPhI since

    Other Content from VECTURA GROUP PLC